Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice
Open Access
- 25 August 2005
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 115 (9), 2434-2443
- https://doi.org/10.1172/jci24819
Abstract
Direct evidence that hyperglycemia, rather than concomitant increases in known risk factors, induces atherosclerosis is lacking. Most diabetic mice do not exhibit a higher degree of atherosclerosis unless the development of diabetes is associated with more severe hyperlipidemia. We hypothesized that normal mice were deficient in a gene that accelerated atherosclerosis with diabetes. The gene encoding aldose reductase (AR), an enzyme that mediates the generation of toxic products from glucose, is expressed at low levels in murine compared with human tissues. Mice in which diabetes was induced through streptozotocin (STZ) treatment, but not nondiabetic mice, expressing human AR (hAR) crossed with LDL receptor–deficient (Ldlr–/–) C57BL/6 male mice had increased aortic atherosclerosis. Diabetic hAR-expressing heterozygous LDL receptor–knockout mice (Ldlr+/–) fed a cholesterol/cholic acid–containing diet also had increased aortic lesion size. Lesion area at the aortic root was increased by STZ treatment alone but was further increased by hAR expression. Macrophages from hAR-transgenic mice expressed more scavenger receptors and had greater accumulation of modified lipoproteins than macrophages from nontransgenic mice. Expression of genes that regulate regeneration of glutathione was reduced in the hAR-expressing aortas. Thus, hAR increases atherosclerosis in diabetic mice. Inhibitors of AR or other enzymes that mediate glucose toxicity could be useful in the treatment of diabetic atherosclerosis.This publication has 45 references indexed in Scilit:
- Expression of Class A Scavenger Receptor Is Enhanced by High Glucose in Vitro and under Diabetic Conditions in VivoOnline Journal of Public Health Informatics, 2005
- Aldose Reductase Inhibition by AS-3201 in Sural Nerve From Patients With Diabetic Sensorimotor PolyneuropathyDiabetes Care, 2004
- Scavenger Receptor Expressed by Endothelial Cells I (SREC-I) Mediates the Uptake of Acetylated Low Density Lipoproteins by Macrophages Stimulated with LipopolysaccharideOnline Journal of Public Health Informatics, 2004
- Increased Risk of Atherosclerosis by Elevated Plasma Levels of Phospholipid Transfer ProteinOnline Journal of Public Health Informatics, 2002
- Aldose reductase activation is a key component of myocardial response to ischemiaThe FASEB Journal, 2001
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Severe Hypercholesterolemia, Hypertriglyceridemia, and Atherosclerosis in Mice Lacking Both Leptin and the Low Density Lipoprotein ReceptorOnline Journal of Public Health Informatics, 2001
- Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trialThe American Journal of Cardiology, 1995
- Tissue distribution of mammalian aldose reductase and related enzymesBiochemical Medicine, 1983
- Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years: Analysis of 229 diabetic patients with and without clinicalevidence of coronary heart disease and comparison to 183 control subjectsThe American Journal of Medicine, 1980